CVE-2024-25371
CVE-2024-25371 is a high-severity vulnerability with a CVSS 3.x base score of 7.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low.
Key facts
- Severity: High (CVSS 3.x base score 7.5)
- EPSS exploit prediction: 0% (32nd percentile)
- Actively exploited: Not listed in CISA KEV
- EU (EUVD) id: EUVD-2024-22704
- Published:
- Last modified:
Description
Gramine before a390e33e16ed374a40de2344562a937f289be2e1 suffers from an Interface vulnerability due to mismatching SW signals vs HW exceptions.
Frequently asked questions
- What is CVE-2024-25371?
- Gramine before a390e33e16ed374a40de2344562a937f289be2e1 suffers from an Interface vulnerability due to mismatching SW signals vs HW exceptions.
- How severe is CVE-2024-25371?
- CVE-2024-25371 has a CVSS 3.x base score of 7.5, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is none, integrity none, and availability high.
- Is CVE-2024-25371 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (32nd percentile), an estimate of the probability of exploitation in the next 30 days.
- How do I fix CVE-2024-25371?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
- Does CVE-2024-25371 have an EU (EUVD) identifier?
- Yes. CVE-2024-25371 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-22704.
- When was CVE-2024-25371 published?
- CVE-2024-25371 was published on 2025-01-10 and last updated on 2026-06-17.